| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |